Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer: a randomized controlled phase II trial
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2012
|
| In: |
Annals of oncology
Year: 2012, Jahrgang: 23, Heft: 5, Pages: 1214-1222 |
| ISSN: | 1569-8041 |
| DOI: | 10.1093/annonc/mdr379 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1093/annonc/mdr379
|
| Verfasserangaben: | J.M. Löhr, S.L. Haas, W.-O. Bechstein, G. Bodoky, K. Cwiertka, W. Fischbach, U.R. Fölsch, D. Jäger, D. Osinsky, J. Prausova, W.E. Schmidt & M.P. Lutz, CT4001 Study Group |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1571698787 | ||
| 003 | DE-627 | ||
| 005 | 20220814104538.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180404s2012 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/annonc/mdr379 |2 doi | |
| 035 | |a (DE-627)1571698787 | ||
| 035 | |a (DE-576)501698787 | ||
| 035 | |a (DE-599)BSZ501698787 | ||
| 035 | |a (OCoLC)1341001630 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Löhr, J.-Matthias |e VerfasserIn |0 (DE-588)13947241X |0 (DE-627)611268973 |0 (DE-576)31199735X |4 aut | |
| 245 | 1 | 0 | |a Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer |b a randomized controlled phase II trial |c J.M. Löhr, S.L. Haas, W.-O. Bechstein, G. Bodoky, K. Cwiertka, W. Fischbach, U.R. Fölsch, D. Jäger, D. Osinsky, J. Prausova, W.E. Schmidt & M.P. Lutz, CT4001 Study Group |
| 264 | 1 | |c 2012 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published: 06 September 2011 | ||
| 500 | |a Gesehen am: 04.04.2018 | ||
| 700 | 1 | |a Haas, Stephan |d 1968- |e VerfasserIn |0 (DE-588)122762606 |0 (DE-627)706033132 |0 (DE-576)332722163 |4 aut | |
| 700 | 1 | |a Jäger, Dirk |d 1964- |e VerfasserIn |0 (DE-588)1032507535 |0 (DE-627)738505323 |0 (DE-576)380074125 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of oncology |d Amsterdam [u.a.] : Elsevier, 1990 |g 23(2012), 5, Seite 1214-1222 |h Online-Ressource |w (DE-627)320428796 |w (DE-600)2003498-2 |w (DE-576)098134345 |x 1569-8041 |7 nnas |a Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer a randomized controlled phase II trial |
| 773 | 1 | 8 | |g volume:23 |g year:2012 |g number:5 |g pages:1214-1222 |g extent:9 |a Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer a randomized controlled phase II trial |
| 856 | 4 | 0 | |u https://doi.org/10.1093/annonc/mdr379 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180404 | ||
| 993 | |a Article | ||
| 994 | |a 2012 | ||
| 998 | |g 1032507535 |a Jäger, Dirk |m 1032507535:Jäger, Dirk |d 910000 |e 910000PJ1032507535 |k 0/910000/ |p 8 | ||
| 998 | |g 122762606 |a Haas, Stephan |m 122762606:Haas, Stephan |d 60000 |d 61100 |e 60000PH122762606 |e 61100PH122762606 |k 0/60000/ |k 1/60000/61100/ |p 2 | ||
| 998 | |g 13947241X |a Löhr, J.-Matthias |m 13947241X:Löhr, J.-Matthias |d 50000 |e 50000PL13947241X |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1571698787 |e 3004909863 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"family":"Löhr","display":"Löhr, J.-Matthias","given":"J.-Matthias","role":"aut"},{"display":"Haas, Stephan","family":"Haas","role":"aut","given":"Stephan"},{"display":"Jäger, Dirk","family":"Jäger","given":"Dirk","role":"aut"}],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title":"Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer","title_sort":"Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer","subtitle":"a randomized controlled phase II trial"}],"note":["Published: 06 September 2011","Gesehen am: 04.04.2018"],"origin":[{"dateIssuedKey":"2012","dateIssuedDisp":"2012"}],"id":{"doi":["10.1093/annonc/mdr379"],"eki":["1571698787"]},"physDesc":[{"extent":"9 S."}],"name":{"displayForm":["J.M. Löhr, S.L. Haas, W.-O. Bechstein, G. Bodoky, K. Cwiertka, W. Fischbach, U.R. Fölsch, D. Jäger, D. Osinsky, J. Prausova, W.E. Schmidt & M.P. Lutz, CT4001 Study Group"]},"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer a randomized controlled phase II trialAnnals of oncology","origin":[{"publisherPlace":"Amsterdam [u.a.] ; Dordrecht [u.a.] ; Oxford","dateIssuedKey":"1990","publisher":"Elsevier ; Kluwer ; Oxford Univ. Press","dateIssuedDisp":"1990-"}],"note":["Gesehen am 12.11.20","Ungezählte Beil.: Supplement"],"pubHistory":["1.1990 -"],"title":[{"title":"Annals of oncology","subtitle":"official journal of the European Society for Medical Oncology","title_sort":"Annals of oncology"}],"id":{"issn":["1569-8041"],"zdb":["2003498-2"],"eki":["320428796"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"320428796","corporate":[{"role":"isb","display":"European Society for Medical Oncology"}],"part":{"issue":"5","text":"23(2012), 5, Seite 1214-1222","year":"2012","pages":"1214-1222","volume":"23","extent":"9"},"language":["eng"]}],"recId":"1571698787"} | ||
| SRT | |a LOEHRJMATTCATIONICLI2012 | ||